Loading stock data...

Gujarat Themis Biosyn Limited

BSE: GUJTHEM

BSE
394.70 -2.35 (-0.59%)

Prev Close

397.05

Open Price

393.25

Volume

6,105

Today Low / High

392.05 / 397.6

52 WK Low / High

192.35 / 424.9

Range

375 - 414

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 394.7, reflecting a change of -2.35 (-0.59187%). The expected target range on the BSE is 375 - 414. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

01 Oct 393.25 0.75%
30 Sep 396.65 0.10%
29 Sep 408.75 -0.37%
26 Sep 405.15 -1.63%
25 Sep 411.00 0.13%
24 Sep 408.00 1.00%
23 Sep 419.10 -2.39%
22 Sep 389.55 5.28%
19 Sep 384.85 0.21%
18 Sep 381.10 0.42%
17 Sep 381.05 1.26%
16 Sep 379.50 0.58%
15 Sep 379.95 0.07%
12 Sep 372.00 1.67%
11 Sep 380.95 0.03%
10 Sep 381.85 -0.96%
09 Sep 383.05 -0.43%
08 Sep 383.55 0.01%
05 Sep 381.50 0.60%
04 Sep 399.25 -4.40%
03 Sep 375.10 4.97%

Gujarat Themis Biosyn Limited Graph

Gujarat Themis Biosyn Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Gujarat Themis Biosyn Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 394.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 394.70 398.65 358.78 - 438.51
402.59 322.08 - 483.11
406.54 284.58 - 528.50
Bearish Scenario 394.70 390.75 351.68 - 429.83
386.81 309.44 - 464.17
382.86 268.00 - 497.72

Overview of Gujarat Themis Biosyn Limited

ISIN

INE942C01045

Industry

Medical - Pharmaceuticals

Vol.Avg

18,565

Market Cap

43,193,831,046

Last Dividend

0.67

Official Website

Visit Website

IPO Date

2002-01-02

DCF Diff

381.52

DCF

14

Financial Ratios Every Investor Needs

Stock Dividend of GUJTHEM

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-04 September 04, 25 0.67 0.67 2025-09-05 2025-10-12
2024-07-15 July 15, 24 0.16667 0.25 2024-07-15 2024-08-22
2024-02-22 February 22, 24 0.5 0.75 2024-02-22 2024-03-11
2023-09-01 September 01, 23 0.13333 1 2023-09-01 2023-10-09
2022-12-02 December 02, 22 0.58667 4.4 2022-12-02 2022-12-21

Stock Rating Details for GUJTHEM

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 150.80 Cr 76.53 Cr 95.74 Cr 0.6349 0.00 Cr 0.00 Cr 82.08 Cr 48.77 Cr 4.48 71.55 Cr 0.3234
2024-03-31 169.82 Cr 68.74 Cr 101.08 Cr 0.5952 3.89 Cr 1.39 Cr 85.40 Cr 59.16 Cr 8.14 83.54 Cr 0.3484
2023-03-31 148.97 Cr 30.78 Cr 118.19 Cr 0.7934 2.93 Cr 1.44 Cr 80.24 Cr 57.97 Cr 7.98 80.22 Cr 0.3891
2022-03-31 114.19 Cr 20.89 Cr 93.30 Cr 0.8170 0.45 Cr 0.83 Cr 59.82 Cr 43.62 Cr 6.01 62.10 Cr 0.3820
2021-03-31 90.43 Cr 21.11 Cr 69.32 Cr 0.7666 0.00 Cr 0.66 Cr 41.67 Cr 30.18 Cr 4.15 41.40 Cr 0.3338

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 12.55 Cr 301.31 Cr 52.93 Cr 248.3820 Cr 30.47 Cr 17.92 Cr 5.05 Cr 225.54 Cr 0.00 Cr 0.00 Cr 1.62 Cr 20.5597 Cr
2024-03-31 6.47 Cr 221.11 Cr 19.74 Cr 201.3761 Cr 2.77 Cr -3.70 Cr 3.33 Cr 129.24 Cr 0.00 Cr 0.00 Cr 31.04 Cr 16.1592 Cr
2023-03-31 6.06 Cr 166.33 Cr 17.18 Cr 149.1459 Cr 0.42 Cr -5.64 Cr 14.62 Cr 53.26 Cr 3.79 Cr 0.00 Cr 37.36 Cr 15.2782 Cr
2022-03-31 0.46 Cr 122.50 Cr 19.18 Cr 103.3215 Cr 1.17 Cr 0.71 Cr 11.61 Cr 32.13 Cr 7.24 Cr 0.58 Cr -12.59 Cr 17.1577 Cr
2021-03-31 3.97 Cr 88.26 Cr 18.32 Cr 69.9473 Cr 4.83 Cr 0.85 Cr 6.05 Cr 21.02 Cr 7.71 Cr 0.51 Cr -34.98 Cr 15.8231 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 91.0286 Cr -111.8182 Cr 26.0143 Cr -25.1216 Cr 5.2247 Cr 11.6939 Cr -116.1502 Cr 48.7717 Cr 29.8899 Cr -1.8167 Cr -1.7194 Cr
2024-03-31 64.2131 Cr -55.2119 Cr -8.5869 Cr -10.4315 Cr 0.4142 Cr 6.4692 Cr -74.6446 Cr 59.1632 Cr 0.0000 Cr -6.9011 Cr 11.2921 Cr
2023-03-31 0.0004 Cr -0.0002 Cr -0.0001 Cr 0.0002 Cr 0.0001 Cr 0.0001 Cr -0.0002 Cr 0.0008 Cr 0.0000 Cr -12.4354 Cr 0.0000 Cr
2022-03-31 40.3132 Cr -29.8318 Cr -13.9951 Cr 26.4157 Cr -3.5137 Cr 0.4608 Cr -13.8975 Cr 59.0345 Cr -3.0727 Cr -10.0006 Cr -5.5607 Cr
2021-03-31 10.5309 Cr -2.2515 Cr -5.1644 Cr 7.4733 Cr 3.1150 Cr 3.9745 Cr -3.0576 Cr 40.8819 Cr -2.0114 Cr -2.3972 Cr -0.0195 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 35.87 Cr 8.00 Cr 27.88 Cr 0.7771 11.89 Cr 9.06 Cr 0.83 14.20 Cr 0.2526
2025-03-31 39.08 Cr 14.70 Cr 24.39 Cr 0.6240 20.97 Cr 12.00 Cr 1.10 17.57 Cr 0.3070
2024-12-31 39.52 Cr 8.86 Cr 30.66 Cr 0.7758 17.30 Cr 12.97 Cr 1.19 19.11 Cr 0.3282
2024-09-30 34.72 Cr 18.34 Cr 16.38 Cr 0.4718 13.96 Cr 10.57 Cr 0.97 15.71 Cr 0.3044
2024-06-30 38.83 Cr 18.48 Cr 20.35 Cr 0.5241 20.35 Cr 13.24 Cr 1.82 18.55 Cr 0.3409

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 12.55 Cr 0.00 Cr 12.55 Cr 31.24 Cr 5.05 Cr 51.97 Cr 225.54 Cr 301.31 Cr 52.93 Cr
2024-12-31 0.00 Cr 0.00 Cr 18.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -223.44 Cr
2024-09-30 8.38 Cr 9.73 Cr 18.11 Cr 28.57 Cr 4.64 Cr 52.25 Cr 178.61 Cr 248.15 Cr 24.72 Cr
2024-06-30 -14.58 Cr 29.17 Cr 14.58 Cr 0.00 Cr 0.00 Cr 14.58 Cr 0.00 Cr 0.00 Cr -201.38 Cr
2024-03-31 8.16 Cr 9.87 Cr 8.16 Cr 27.59 Cr 3.33 Cr 47.56 Cr 129.24 Cr 221.11 Cr 19.74 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 12.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 12.97 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 10.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 13.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 15.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2024-08-09 August 09, 24 3:2
2023-10-10 October 10, 23 5:1

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹743.20 ₹88,993,515,610.00 ₹72,416.00

Key Executives

Chief Technical Officer
Mr. Do-Seon Kim

Gender: male

Year Born:

Senior Executive
Mr. Rajneesh Kedarnath Anand

Gender: male

Year Born: 1954

Chief Financial Officer
Mr. Bhavik Shah

Gender: male

Year Born:

Chief Executive Officer
Mr. Tapas Bhudebendranath Guhathakurata

Gender: male

Year Born:

Company Secretary & Compliance Officer
Mr. Vineet G. Gawankar

Gender: male

Year Born:

FAQs about Gujarat Themis Biosyn Limited

Who is the CEO of the company?

The CEO is Tapas Bhudebendranath Guhathakurata.

What is the current market price of the stock?

The current price is ₹396.40.

What is the 52-week price range?

The range is ₹192.35-424.9.

What is the market capitalization of the company?

The market capitalization is ₹4,319.38 crores.

What is the dividend yield?

The dividend yield is 0.17%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 97.04.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Gujarat Themis Biosyn Limited (ISIN: INE942C01045) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹4,319.38 crores and an average daily volume of 18,565 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.67.